Global Preformulation Analysis Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256534

Publication Date:

March 3, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Preformulation Analysis Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Preformulation analysis service refers to a range of scientific and analytical techniques used to evaluate the physical, chemical, and biopharmaceutical properties of a drug substance or active pharmaceutical ingredient (API) before it is formulated into a dosage form.
The purpose of preformulation analysis is to understand the characteristics and behavior of the drug substance, which can help in the development of an effective and stable formulation. It involves studying various parameters such as solubility, stability, particle size, polymorphism, pH-solubility profile, and compatibility with excipients.
Preformulation analysis services are typically offered by contract research organizations (CROs) or analytical laboratories. These services can provide valuable information to pharmaceutical companies during the early stages of drug development, helping them make informed decisions about formulation strategies, dosage forms, and potential issues that may arise during formulation or manufacturing processes.
United States market for Preformulation Analysis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Preformulation Analysis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Preformulation Analysis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Preformulation Analysis Service players cover Alfa Chemistry, Zhejiang Langhua Pharmaceutical, Pion, Almac, Viva Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧reformulation Analysis Service Industry Forecast鈥� looks at past sales and reviews total world Preformulation Analysis Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Preformulation Analysis Service sales for 2025 through 2031. With Preformulation Analysis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preformulation Analysis Service industry.
This Insight Report provides a comprehensive analysis of the global Preformulation Analysis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preformulation Analysis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Preformulation Analysis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preformulation Analysis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preformulation Analysis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Preformulation Analysis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Crystallinity Determination
Hygroscopicity
Particle Characterization Analysis
Other
Segmentation by Application:
Enterprise
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alfa Chemistry
Zhejiang Langhua Pharmaceutical
Pion
Almac
Viva Biotech
Medcent Pharma
Sharp Services
BOC Sciences
Formurex
Analytics
Aspira Pharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Preformulation Analysis Service 麻豆原创 Size (2020-2031)
2.1.2 Preformulation Analysis Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Preformulation Analysis Service by Country/Region (2020, 2024 & 2031)
2.2 Preformulation Analysis Service Segment by Type
2.2.1 Crystallinity Determination
2.2.2 Hygroscopicity
2.2.3 Particle Characterization Analysis
2.2.4 Other
2.3 Preformulation Analysis Service 麻豆原创 Size by Type
2.3.1 Preformulation Analysis Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Preformulation Analysis Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Preformulation Analysis Service Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Preformulation Analysis Service 麻豆原创 Size by Application
2.5.1 Preformulation Analysis Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Preformulation Analysis Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Preformulation Analysis Service 麻豆原创 Size by Player
3.1 Preformulation Analysis Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Preformulation Analysis Service Revenue by Player (2020-2025)
3.1.2 Global Preformulation Analysis Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Preformulation Analysis Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preformulation Analysis Service by Region
4.1 Preformulation Analysis Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Preformulation Analysis Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Preformulation Analysis Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Preformulation Analysis Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Preformulation Analysis Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Preformulation Analysis Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Preformulation Analysis Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Preformulation Analysis Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Preformulation Analysis Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preformulation Analysis Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Preformulation Analysis Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Preformulation Analysis Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preformulation Analysis Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Preformulation Analysis Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Preformulation Analysis Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preformulation Analysis Service by Region (2020-2025)
8.2 Middle East & Africa Preformulation Analysis Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Preformulation Analysis Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Preformulation Analysis Service 麻豆原创 Forecast
10.1 Global Preformulation Analysis Service Forecast by Region (2026-2031)
10.1.1 Global Preformulation Analysis Service Forecast by Region (2026-2031)
10.1.2 Americas Preformulation Analysis Service Forecast
10.1.3 APAC Preformulation Analysis Service Forecast
10.1.4 Europe Preformulation Analysis Service Forecast
10.1.5 Middle East & Africa Preformulation Analysis Service Forecast
10.2 Americas Preformulation Analysis Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Preformulation Analysis Service Forecast
10.2.2 Canada 麻豆原创 Preformulation Analysis Service Forecast
10.2.3 Mexico 麻豆原创 Preformulation Analysis Service Forecast
10.2.4 Brazil 麻豆原创 Preformulation Analysis Service Forecast
10.3 APAC Preformulation Analysis Service Forecast by Region (2026-2031)
10.3.1 China Preformulation Analysis Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Preformulation Analysis Service Forecast
10.3.3 Korea 麻豆原创 Preformulation Analysis Service Forecast
10.3.4 Southeast Asia 麻豆原创 Preformulation Analysis Service Forecast
10.3.5 India 麻豆原创 Preformulation Analysis Service Forecast
10.3.6 Australia 麻豆原创 Preformulation Analysis Service Forecast
10.4 Europe Preformulation Analysis Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Preformulation Analysis Service Forecast
10.4.2 France 麻豆原创 Preformulation Analysis Service Forecast
10.4.3 UK 麻豆原创 Preformulation Analysis Service Forecast
10.4.4 Italy 麻豆原创 Preformulation Analysis Service Forecast
10.4.5 Russia 麻豆原创 Preformulation Analysis Service Forecast
10.5 Middle East & Africa Preformulation Analysis Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Preformulation Analysis Service Forecast
10.5.2 South Africa 麻豆原创 Preformulation Analysis Service Forecast
10.5.3 Israel 麻豆原创 Preformulation Analysis Service Forecast
10.5.4 Turkey 麻豆原创 Preformulation Analysis Service Forecast
10.6 Global Preformulation Analysis Service Forecast by Type (2026-2031)
10.7 Global Preformulation Analysis Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Preformulation Analysis Service Forecast
11 Key Players Analysis
11.1 Alfa Chemistry
11.1.1 Alfa Chemistry Company Information
11.1.2 Alfa Chemistry Preformulation Analysis Service Product Offered
11.1.3 Alfa Chemistry Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Alfa Chemistry Main Business Overview
11.1.5 Alfa Chemistry Latest Developments
11.2 Zhejiang Langhua Pharmaceutical
11.2.1 Zhejiang Langhua Pharmaceutical Company Information
11.2.2 Zhejiang Langhua Pharmaceutical Preformulation Analysis Service Product Offered
11.2.3 Zhejiang Langhua Pharmaceutical Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Zhejiang Langhua Pharmaceutical Main Business Overview
11.2.5 Zhejiang Langhua Pharmaceutical Latest Developments
11.3 Pion
11.3.1 Pion Company Information
11.3.2 Pion Preformulation Analysis Service Product Offered
11.3.3 Pion Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Pion Main Business Overview
11.3.5 Pion Latest Developments
11.4 Almac
11.4.1 Almac Company Information
11.4.2 Almac Preformulation Analysis Service Product Offered
11.4.3 Almac Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Almac Main Business Overview
11.4.5 Almac Latest Developments
11.5 Viva Biotech
11.5.1 Viva Biotech Company Information
11.5.2 Viva Biotech Preformulation Analysis Service Product Offered
11.5.3 Viva Biotech Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Viva Biotech Main Business Overview
11.5.5 Viva Biotech Latest Developments
11.6 Medcent Pharma
11.6.1 Medcent Pharma Company Information
11.6.2 Medcent Pharma Preformulation Analysis Service Product Offered
11.6.3 Medcent Pharma Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Medcent Pharma Main Business Overview
11.6.5 Medcent Pharma Latest Developments
11.7 Sharp Services
11.7.1 Sharp Services Company Information
11.7.2 Sharp Services Preformulation Analysis Service Product Offered
11.7.3 Sharp Services Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Sharp Services Main Business Overview
11.7.5 Sharp Services Latest Developments
11.8 BOC Sciences
11.8.1 BOC Sciences Company Information
11.8.2 BOC Sciences Preformulation Analysis Service Product Offered
11.8.3 BOC Sciences Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 BOC Sciences Main Business Overview
11.8.5 BOC Sciences Latest Developments
11.9 Formurex
11.9.1 Formurex Company Information
11.9.2 Formurex Preformulation Analysis Service Product Offered
11.9.3 Formurex Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Formurex Main Business Overview
11.9.5 Formurex Latest Developments
11.10 Analytics
11.10.1 Analytics Company Information
11.10.2 Analytics Preformulation Analysis Service Product Offered
11.10.3 Analytics Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Analytics Main Business Overview
11.10.5 Analytics Latest Developments
11.11 Aspira Pharma
11.11.1 Aspira Pharma Company Information
11.11.2 Aspira Pharma Preformulation Analysis Service Product Offered
11.11.3 Aspira Pharma Preformulation Analysis Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Aspira Pharma Main Business Overview
11.11.5 Aspira Pharma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.